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We appreciate the thorough commentary by Drs. Franks
and Nettleton (1). The major ﬁnding of our paper (2) was
that interaction between the cyclin-dependent kinase 5 reg-
ulatory subunit-associated protein 1-like 1 (CDKAL1) gene
and total energy intake (TEI) affected hemoglobin A1c
levels in apparently healthy Japanese men. Giventhe limited
space in which to respond to Franks and Nettleton, we will
focus on a few of the more pertinent issues.
First, we are aware of the limitations of our study, in-
cluding its low statistical power due to the small sample
size, and we agree with Franks and Nettleton regarding
the consequences of a low-powered study in general. These
consequences can only be overcome by selecting a larger
cohort. Thus, our paper is, at best, an exploratory analysis
rather than a validation analysis of the effect of a well-
studied CDKAL1 polymorphism.
Franks and Nettleton raised a question with regard to the
accuracy ofthe food frequency questionnaire (FFQ) used for
measuring TEI. We agree that assessing the validity of the
dietary intake method is essential. The FFQ we used has
been compared with 7-day dietary records and has been
demonstrated to have a signiﬁcant correlation with TEI
(3). Thus, we believe this method allowed us to place par-
ticipants into broad categories along a distribution of TEI
(e.g., tertiles, as we used in the study). Body height was also
taken into account as a means of reducing measurement bias
in the calculation of TEI from FFQ (4). The possible mea-
surement bias was noted as a limitation of the study in our
original report (2).
Franks and Nettleton raised an issue regarding consis-
tency, taking Hill’s criteria (5) as an example and referring
to 2 intervention studies (6, 7) and 1 cohort study (8) that
were claimed to not support our data. One of the interven-
tion studies (6), which Franks coauthored, involved a high-
risk diabetic population, the majority of which received
lifestyle intervention or medication. Signiﬁcant differences
exist in the characteristics of the populations, including
mean body mass index, which was 34 in Franks’ group
and 23 in our group. The cohort study (8), also coauthored
by Franks, accounted for an interaction between the gene
and physical activity, dichotomized into active and inactive
states by means of a computer-assisted questionnaire.
Whether or how TEI was measured in this group does not
seem to be explained in the paper (8). Thus, the context
and aims of these studies seem to be so remote from ours
that we cannot infer any indication of consistency or
inconsistency.
In addition, Franks and Nettleton questioned the biologic
plausibility of our ﬁndings. CDKAL1 is involved in b-cell
function, and polymorphisms within the gene have been
repeatedly shown to affect blood glucose levels and insulin
secretion, but not fasting glucose levels, after a glucose tol-
erance test (9). Therefore, we think it is reasonable to spec-
ulate on and test whether the CDKAL1 gene 3 TEI
interaction correlates with blood glucose levels. Here, we
would like to reiterate that although we observed a correla-
tion with hemoglobin A1c, we did not observe a correlation
with fasting glucose levels (2).
As for causality, Franks and Nettleton also suggested
that the effect of the CDKAL1 variant might be to
modify TEI but not blood glucose level. This assertion is
logically true, and to ascertain the possibility one needs to
stratify the population according to blood glucose level,
genotype the participants, and survey TEI under an ad lib
diet.
The commentary by Franks and Nettleton provided us
with an opportunity to review our own study. We agree that
future studies using larger cohorts are needed to validate our
novel ﬁnding that the CDKAL1 gene 3 TEI interaction
affects blood glucose level. Such studies may highlight
other environmental or genetic interaction factors that are
prerequisites for this effect.
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